[304 Pages Report] Global demand for vascular patches is set to grow by 5.8% from 2021 to 2031, with an estimated market value of around US$ 136.9 Million as of 2021. As per Future Market Insights (FMI), biologic vascular patches by materials held a share of about 52.9% in 2020 within the global market.
Market Outlook:
Data Points | Market Insights |
---|---|
Vascular Patches Market Market Value 2020 | US$ 130.8 Million |
Vascular Patches Market Market Value 2021 | US$ 136.9 Million |
Vascular Patches Market Market Value 2031 | US$ 241.4 Million |
CAGR 2021 to 2031 | 5.8% |
Market Share of Top 5 Countries | 56.1% |
Global manufacturing front-runners in the vascular patches market are developing comprehensive cardiovascular applications for available prosthetic devices. Strategic approaches followed by the key players thus include extensive applications following the conduction of additional clinical investigations on existing vascular products.
Rising research activities for the treatment of various cardiovascular prosthetic applications are gaining traction. This progressive setup encouraging vascular patch application for the treatment of various cardiovascular diseases is anticipated to create impressive prospects for vascular patch market players to invest in.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for vascular patches expanded at a CAGR of 4.2% over the last five years (2016 to 2020). The sales of vascular patches accounted for nearly 2.7% of the overall cardiac prosthetics device market which was valued at ~US$ 5.1 Billion in 2020.
Vascular patches are used in cardiovascular diseases and the reconstruction of tissue or arteries to repair aneurysms, arterial stenosis, and unwanted blood clots. Typical surgeries are performed on arteries of the heart (coronary arterial bypass), kidneys, legs (femoropopliteal bypass), and abdominal aorta.
The progress of the vascular patches market is motivated by the rising prevalence of cardiovascular diseases worldwide. This factor is supported by the increasing consumption of tobacco and smoking globally, indicating a change in lifestyle and stress. Additionally, increasing spending on healthcare infrastructure development post-COVID-19 pandemic is also helping the vascular patches market gain momentum.
Rising awareness regarding early stroke management in the long run and diagnosis has propelled the sales of vascular patches. Cardiovascular diseases have been the key motivator in fuelling the growth of the market, as the number of affected cases over the globe continues to rise.
According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide. As per a WHO data sheet published in June 2021, 17.9 million people died from cardiovascular illnesses in 2019, accounting for 32 percent of all fatalities worldwide. Coronary heart disease and stroke were responsible for 85 percent of these deaths. Low-income countries accounted for more than 3/4 of all deaths caused by cardiovascular disease. In 2019, cardiovascular disorders caused 38 percent of the 17 million unexpected deaths among people under the age of 70 due to non-communicable diseases.
Patch angioplasty is normally performed after carotid endarterectomy. Randomized planned preliminaries and meta-examinations have helped in perioperative and long-term stroke counteraction, and also reduced the cases of recurrent restenosis, which is the section of the blocked vessel that is narrowed again after reconstruction and will further lead to blockage, requiring re-stenting or bypass surgery. The fact that the utilization of vein patches is viewed as the best quality level for patch closure, advancements in synthetic and biological materials linked to vein-related vascular patches find multiple applications in several other cardiovascular disease indications.
Future bioengineered patches aim to upgrade patch merits, both by accomplishing negligible stroke hazard, and long-term paces of restenosis, just as by limiting the danger of related complications of the prosthetic patch such as pseudo aneurysm development.
New-generation patches come with long-term stability, durability, low risk of ischemic strokes, easy handling properties, enhanced usability, and properties that push late degeneration. These vascular devices have assisted surgeons with cardiovascular surgical procedures, thus boosting product demand. Thus, the growth of the vascular patches market is influenced by the above-mentioned factors and will continue to enhance over the forecasted years.
The market is expected to expand at a significant rate over the next ten years at a CAGR growth value close to 5.8% and offers an absolute $ opportunity of US$ 7.2 Million.
The above-mentioned factors are primarily insightful, concerning the global sales growth of the vascular patches market, and are anticipated to persistently propel the market growth over the forecasted period of 2021 to 2031.
Factors favoring vascular patch manufacturers to grow their businesses include the development of novel products and technologies which are appropriate for utilization and for strategic acquisitions through technology transfer activities, thus propelling sales growth as well as market positioning for key manufacturers within the vascular patches sphere.
Advancements in vascular surgical operations and vascular illness treatment will depend upon upcoming technological advancements. On the horizon are superior medical treatments to arrest or even oppose atherosclerosis. The availability of statin drugs is just the beginning, and their use has already reduced the case volumes of heart attacks, strokes, and death. Applications of statin drugs will prove to be effective, enhance treatments, and help enhance treatment outcomes.
Glimpses of computer-assisted 3-dimensional tool navigational equipment are emerging. The probability of radiation-based treatments being obsolete is rising, thereby decreasing the risks associated with such procedures to patients and operators. Advances in robotic technology will also lower radiation exposure and facilitate device placement.
Patient outcomes and satisfactory results of endovascular management will also improve with advanced stent research and development activities. These factors collectively present opportunistic effects on the growth of the vascular patches market.
The factors restraining the demand for vascular patches include the challenges associated with post-surgical complications like suture line folds, suture line bleeding, and vascular trauma, which further induce a restrictive impact on the overall vascular patches market.
In addition, the availability of skilled physicians is critical.
Vascular specialists offer significant assistance to the medical care framework. They are equipped for treating a wide scope of sickness processes that influence both the venous and the blood vessel frameworks. Their essence widens the intricacy and variety of administrations that a medical care framework can offer, both in the short-term setting and in ongoing settings because of their capacity to control hemorrhages.
These factors are identified as significant barriers to vascular surgeries in many regions, which are further set to impede the growth of the vascular patches market in the coming years.
High Prevalence of Cardiovascular Diseases Makes the USA a Key Market
The USA dominated the North American market with a total share of about 90.7% in 2020 and is projected to continue registering high growth throughout the forecast period. The high prevalence of cardiovascular diseases, as well as associated chronic ailments within the population in the country, are related factors to the USA being considered the largest market for vascular patches.
Favorable Government Policies to Spur Growth in Germany
Germany is set to exhibit a CAGR of nearly 5.7% in the Europe vascular patches market during the forecast period. The growth is associated with the presence of governing bodies that provide rules and regulations for the predictive management of surgeries within the country in accordance with national and regional guidelines.
Germany has been recording high demand for vascular patch surgeries, owing to the presence of a large population base with unhealthy lifestyle habits such as smoking.
China to Remain Leading Vascular Patches Market in East Asia
China holds a 43.3% share of the East Asia market in 2020 and is projected to expand at a CAGR of 8.1% during the forecast period. China records a high prevalence of cardiovascular diseases, which are also among the leading causes of death within the country, owing to the consumption of a high sodium diet, seafood, a sedentary lifestyle, etc.
Environmental factors such as air pollution are also one of major causes of cardiovascular diseases within the country. These metrics support the vascular patches market growth in the coming year.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Biological Patches Sales to Top Among Materials
Biologic patch projects lucrative growth at a CAGR of 4.9% until the end of the forecast period, with an expected market share of over 52.2% in 2031 due to the increased adoption. Biologic patches are high-quality patches that are used for precise closure during vascular reconstruction procedures.
Technological Advancements in Peripheral Vascular Reconstruction to Spur Sales
Peripheral vascular reconstruction is forecast to showcase a CAGR of 9.0% until the end of the forecast period, with a projected market share of 30.9% in 2022. The growth in this segment is attributed to the increasing technological developments with respect to peripheral vascular devices such as plaque modification devices, catheters, and angioplasty stents.
Demand in Hospitals to Account for Maximum Sales
Hospitals as end users lead the vascular patches market with a 39.9% market share in 2020. The presence of skilled professionals and the accessibility to advanced devices in hospitals are the primary driving factors for this industry.
Key players are focusing on the development and launch of novel vascular patches for the treatment of different types of cardiac diseases. For established players within the industry, the returns on investment are higher for cardiac therapeutics owing to the right of market exclusivity, recognition, and government incentives to new and innovative options for treatment.
Similarly, recent developments related to companies manufacturing vascular patch products have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2021 to 2031 |
Historical Data Available for | 2016 to 2020 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
Key Market Segments Covered | Material, Application, End User, and Region |
Key Companies Profiled | Braile Biomedica; Baxter International; Getinge Ab (Maquet); B. Braun Melsungen AG; W. L. Gore & Associates; Admedus; Cryolife; Edwards Lifesciences; Labcor Laboratórios; Terumo Corporation; BiOTECK; Lab Medica; Tissuemed; InSitu Technologies; LeMaitre Vascular, Inc.; Becton, Dickinson, and Company; CARITAS. |
Pricing | Available upon Request |
The vascular patches market is expected to reach $254 Million by 2032.
The market growth rate for vascular patches is expected to be a CAGR of 5.8% through 2032.
North America held the highest market share of vascular patches.
The market value for vascular patches amounts to $144.8 Million in 2022.
1. Executive Summary | Vascular Patches Market 1.1. Global Market Outlook 1.2. Global CAGR Market Outlook 1.3. Market Outlook Summary 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Key Disease Epidemiology 4.2. Adoption Analysis 4.3. Promotional Strategies 4.4. PESTLE 4.5. Porters Analysis 4.6. Value Chain Analysis 4.7. Product USP Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare spending outlook 5.1.2. Rise in Ageing Population 5.1.3. Global GDP outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Increasing Adoption of Advance vascular Patches 5.2.3. Growing Awareness for Cardiac Disorder 5.2.4. Technological Advancements in Vascular Patches 5.2.5. Cost of vascular patches 5.2.6. Regulatory dynamics 5.2.7. Reimbursement scenario 5.2.8. Prevalence rate 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 5.4. Global Supply Demand Analysis 6. COVID-19 Crisis Analysis 6.1. Current COVID-19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic Analysis 6.4. COVID-19 and Impact Analysis 6.4.1. By Materials 6.4.2. By Application 6.4.3. By End User 7. Global Market Demand (in Volume ‘000 Units) Analysis 2017 to 2021 and Forecast, 2022 to 2032 7.1. Historical Market Volume (‘000 Units) Analysis, 2017 to 2021 7.2. Current and Future Market Volume (‘000 Units) Projections, 2022 to 2032 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product Type 8.2. Global Average Pricing Analysis Benchmark 9. Global Market Demand (in Value or Size in US$ Million) Analysis 2016 to 2020 and Forecast, 2021 to 2031 9.1. Historical Market Value (US$ Million) Analysis, 2016 to 2020 9.2. Current and Future Market Value (US$ Million) Projections, 2021 to 2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, By Materials 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Materials, 2016 to 2020 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Materials, 2021 to 2031 10.3.1. Biologic 10.3.2. Synthetic 10.4. Attractiveness Analysis By Materials 11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Application, 2016 to 2020 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2021 to 2031 11.3.1. Carotid Endarterectomy 11.3.2. Open Repair of Abdominal Aneurysm 11.3.3. Vascular Bypass Surgery 11.3.4. Others 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2016 to 2020 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2021 to 2031 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Trauma Care Centers 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2016 to 2020 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2021 to 2031 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East & Africa 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2016 to 2020 14.4. Current and Future Market Size (US$ Million) and Volume (Units)Forecast By Market Taxonomy, 2021 to 2031 14.4.1. By Materials 14.4.2. By Application 14.4.3. By End User 14.5. Market Attractiveness Analysis 14.5.1. By Materials 14.5.2. By Application 14.5.3. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. USA Market Analysis 2016 to 2020 and Forecast 2021 to 2031 15.1. Introduction 15.2. Market Trends 15.3. Historical Market Size (US$ Million) and Volume Analysis By Market Taxonomy, 2016 to 2020 15.4. Market Size (US$ Million) & Volume Analysis and Forecast By Market Taxonomy, 2021 to 2031 15.4.1. By Materials 15.4.2. By Application 15.4.3. By End User 15.5. Market Attractiveness Analysis 15.5.1. By Materials 15.5.2. By Application 15.5.3. By End User 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2016 to 2020 16.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021 to 2031 16.4.1. By Materials 16.4.2. By Application 16.4.3. By End User 16.5. Market Attractiveness Analysis 16.5.1. By Materials 16.5.2. By Application 16.5.3. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031 17.1. Introduction 17.2. Pricing Analysis 17.3. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2016 to 2020 17.4. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2021 to 2031 17.4.1. By Materials 17.4.2. By Application 17.4.3. By End User 17.5. Market Attractiveness Analysis 17.5.1. By Materials 17.5.2. By Application 17.5.3. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031 18.1. Introduction 18.2. Pricing Analysis 18.3. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2016 to 2020 18.4. Current and Future Market Size (US$ Million) and Volume (Units)Forecast By Market Taxonomy, 2021 to 2031 18.4.1. By Materials 18.4.2. By Application 18.4.3. By End User 18.5. Market Attractiveness Analysis 18.5.1. By Materials 18.5.2. By Application 18.5.3. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2016 to 2020 19.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 19.4.1. By Materials 19.4.2. By Application 19.4.3. By End User 19.5. Market Attractiveness Analysis 19.5.1. By Materials 19.5.2. By Application 19.5.3. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031 20.1. Introduction 20.2. Pricing Analysis 20.3. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2016 to 2020 20.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 20.4.1. By Materials 20.4.2. By Application 20.4.3. By End User 20.5. Market Attractiveness Analysis 20.5.1. By Materials 20.5.2. By Application 20.5.3. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. MEA Market Analysis 2016 to 2020 and Forecast 2021 to 2031 21.1. Introduction 21.2. Pricing Analysis 21.3. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2016 to 2020 21.4. Current and Future Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031 21.4.1. By Materials 21.4.2. By Application 21.4.3. By End User 21.5. Market Attractiveness Analysis 21.5.1. By Materials 21.5.2. By Application 21.5.3. By End User 21.6. Market Trends 21.7. Key Market Participants - Intensity Mapping 21.8. Drivers and Restraints - Impact Analysis 22. Country Level Market Analysis 2016 to 2020 and Forecast 2021 to 2031 22.1. Introduction 22.1.1. Market Value Proportion Analysis 22.1.2. Global VS. Country Growth Comparison 22.2. USA Market Analysis 22.2.1. By Materials 22.2.2. By Application 22.2.3. By End User 22.3. Canada Market Analysis 22.3.1. By Materials 22.3.2. By Application 22.3.3. By End User 22.4. Mexico Market Analysis 22.4.1. By Materials 22.4.2. By Application 22.4.3. By End User 22.5. Brazil Market Analysis 22.5.1. By Materials 22.5.2. By Application 22.5.3. By End User 22.6. Argentina Market Analysis 22.6.1. By Materials 22.6.2. By Application 22.6.3. By End User 22.7. Germany Market Analysis 22.7.1. By Materials 22.7.2. By Application 22.7.3. By End User 22.8. Italy Market Analysis 22.8.1. By Materials 22.8.2. By Application 22.8.3. By End User 22.9. France Market Analysis 22.9.1. By Materials 22.9.2. By Application 22.9.3. By End User 22.10. UK Market Analysis 22.10.1. By Materials 22.10.2. By Application 22.10.3. By End User 22.11. Spain Market Analysis 22.11.1. By Materials 22.11.2. By Application 22.11.3. By End User 22.12. BENELUX Market Analysis 22.12.1. By Materials 22.12.2. By Application 22.12.3. By End User 22.13. Russia Market Analysis 22.13.1. By Materials 22.13.2. By Application 22.13.3. By End User 22.14. China Market Analysis 22.14.1. By Materials 22.14.2. By Application 22.14.3. By End User 22.15. Japan Market Analysis 22.15.1. By Materials 22.15.2. By Application 22.15.3. By End User 22.16. South Korea Market Analysis 22.16.1. By Materials 22.16.2. By Application 22.16.3. By End User 22.17. India Market Analysis 22.17.1. By Materials 22.17.2. By Application 22.17.3. By End User 22.18. Malaysia Market Analysis 22.18.1. By Materials 22.18.2. By Application 22.18.3. By End User 22.19. Indonesia Market Analysis 22.19.1. By Materials 22.19.2. By Application 22.19.3. By End User 22.20. Thailand Market Analysis 22.20.1. By Materials 22.20.2. By Application 22.20.3. By End User 22.21. Australia Market Analysis 22.21.1. By Materials 22.21.2. By Application 22.21.3. By End User 22.22. New Zealand Market Analysis 22.22.1. By Materials 22.22.2. By Application 22.22.3. By End User 22.23. GCC Countries Market Analysis 22.23.1. By Materials 22.23.2. By Application 22.23.3. By End User 22.24. Turkey Market Analysis 22.24.1. By Materials 22.24.2. By Application 22.24.3. By End User 22.25. South Africa Market Analysis 22.25.1. By Materials 22.25.2. By Application 22.25.3. By End User 23. Market Structure Analysis 23.1. Market Analysis by Tier of Companies (Vascular Patches) 23.2. Market Share Analysis of Top Players (%) 23.3. Brand Share Analysis (%), By USA 23.4. Market Presence Analysis 23.4.1. By Regional Footprint of Players 23.4.2. Device foot print by Players 23.4.3. Channel Foot Print by Players 24. Competition Analysis 24.1. Competition Dashboard 24.2. Competition Benchmarking 24.3. Competition Deep Dive 24.3.1. Braile Biomedica 24.3.1.1. Overview 24.3.1.2. Product Portfolio 24.3.1.3. Profitability by Market Segments (Product/Channel/Region) 24.3.1.4. Company Key Financial 24.3.1.5. Sales Footprint 24.3.1.6. Strategy Overview 24.3.2. Baxter International 24.3.3. Getinge Ab (Maquet) 24.3.4. B. Braun Melsungen AG 24.3.5. W. L. Gore & Associates 24.3.6. Admedus 24.3.7. Cryolife 24.3.8. Edwards Lifesciences 24.3.9. Labcor Laboratórios 24.3.10. Terumo Corporation 24.3.11. BiOTECK 24.3.12. Lab Medica 24.3.13. Tissuemed 24.3.14. InSitu Technologies 24.3.15. LeMaitre Vascular, Inc. 24.3.16. Becton, Dickinson, and Company 24.3.17. CARITAS 25. Assumptions and Acronyms Used 26. Research Methodology
Explore Healthcare Insights
View Reports